{"filings":[{"id":1249317,"accession_number":"0001193125-26-281037","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-06-24T20:05:20+00:00","items":["3.01"],"status":"ready","headline":"Definitive Healthcare receives Nasdaq bid-price deficiency notice; has until Dec 15, 2026 to comply","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq notified Definitive Healthcare on June 18, 2026 that its stock failed to meet $1.00 minimum bid price for 30 consecutive days.","Company has 180 calendar days, until December 15, 2026, to regain compliance by closing at $1.00+ for at least 10 consecutive days.","If not cured, Definitive Healthcare may qualify for an additional 180-day period, potentially requiring a reverse stock split.","There is no immediate impact on DH stock listing or trading; it continues on Nasdaq under symbol 'DH'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":888210,"accession_number":"0001193125-26-259530","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-06-05T20:05:17+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare shareholders approve 15M share increase under 2021 equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment to 2021 Equity Incentive Plan approved: shares authorized increase from 30.97M to 45.97M (15M new shares).","All three Class II director nominees elected: Chris Egan, Sastry Chilukuri, Samuel Hamood.","Deloitte & Touche LLP ratified as independent auditor for fiscal year 2026; 130.7M for, 0.7M against.","Advisory say-on-pay approved with 108.8M for, 12.7M against, 19.2k abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96363,"accession_number":"0001193125-26-211946","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $55.9M (-6% YoY); net loss $192.4M on $197M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $55.9M, at top end of guidance, down 6% from $59.2M in Q1 2025.","Net loss of $(192.4)M includes $197.2M goodwill impairment; adjusted net income rose to $8.5M from $7.0M.","Adjusted EBITDA $15.3M (27% margin) vs $14.7M (25%) YoY; operating cash flow $11.6M, unlevered FCF $18.0M.","Q2 2026 guidance: revenue $55-56M, adj. EBITDA $13.5-14.5M. Full-year: revenue $220-226M, adj. EBITDA $55-59M.","Customer wins include a six-figure multi-year life sciences deal and Monocl expansion from a biopharma acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":55929000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96362,"accession_number":"0001193125-26-149605","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Definitive Healthcare terminates nominating agreement with Spectrum; designee resigned","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spectrum had right to designate one director nominee while holding ≥5% of outstanding shares.","Jeff Haywood, Spectrum's designee, resigned from board on March 30, 2026.","On April 3, 2026, Definitive Healthcare and Spectrum permanently terminated the Nominating Agreement.","Termination removes Spectrum's board nomination right effective immediately.","No reason for termination disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96361,"accession_number":"0001193125-26-142104","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-04-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare director Jeff Haywood resigns from Board and Compensation Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeff Haywood resigned from the Board and Compensation Committee effective March 30, 2026.","Resignation was not due to any disagreement with the Company's operations, policies, or practices.","Board size reduced from 9 to 8 members; Compensation Committee reduced from 3 to 2 members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110209,"accession_number":"0001193125-26-076609","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue $61.5M (-1% YoY); full year net loss includes $196.1M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $61.5M vs $62.3M prior year; adjusted EBITDA $18.0M (29% margin) vs $17.5M (28%).","Full year 2025 revenue $241.5M vs $252.2M; adjusted net income $34.9M vs $55.1M.","Net loss for full year 2025 was $199.3M, including $196.1M goodwill impairment; prior year loss $591.4M with $688.9M impairment.","Q1 2026 revenue guidance $54–56M; full year 2026 revenue guidance $220–226M, below 2025 actual of $241.5M.","Customer wins: large health system for Population Intelligence; global rare disease firm for US market expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":241521000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126766,"accession_number":"0001193125-25-269559","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue $60M (-4% YoY); net loss $17.8M; raises FY revenue guidance low end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $60.0M (-4% vs $62.7M in Q3 2024); net loss $17.8M (vs $187.8M including $228.2M goodwill impairment).","Adjusted EBITDA $18.9M (32% margin), down from $20.6M (33% margin) YoY; adjusted net income $9.7M.","Q4 2025 revenue guidance $59-60M; FY 2025 revenue guidance raised to $239-240M (low end up $2M).","Customer wins: large biopharma and medical device company selected Definitive Healthcare for commercial intelligence.","Cash flow from operations $15.7M; unlevered free cash flow $17.9M in Q3 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":179987000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143552,"accession_number":"0000950170-25-105037","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $60.8M (-5% YoY); raises FY revenue guidance bottom by $3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net loss $(9.3)M vs $(306.2)M (prior year included $363.6M goodwill impairment).","Adjusted net income $9.7M, down from $14.2M in Q2 2024; adjusted EBITDA $18.7M (31% margin).","Q3 2025 revenue guidance $59-60M; FY 2025 raised to $237-240M from $234-240M.","Adjusted net income per diluted share for Q3 guided at $0.05-0.06; FY at $0.22-0.23.","Customer wins include a revenue cycle management firm and a digital health org returning after non-renewal."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":119941000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143551,"accession_number":"0000950170-25-097966","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Jill Larsen resigns from Definitive Healthcare board; Scott Stephenson named Compensation Committee Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jill Larsen resigned from the Board and as Chair of the Human Capital Management and Compensation Committee effective July 21, 2025.","Resignation due to increased responsibilities at her current employer, not due to any disagreement with the Company.","Board size reduced from 10 to 9 members.","Scott Stephenson appointed as member and Chair of the Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143550,"accession_number":"0000950170-25-092187","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare eliminates COO role; Shamsuddin Jensen to depart Aug 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO position eliminated; Kate Shamsuddin Jensen will remain employed through August 1, 2025.","Departure treated as termination without 'cause' under company's plans and agreements.","No replacement named; role eliminated as part of organizational design planning.","Agreement reached on June 25, 2025; effective date of departure is August 1, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161746,"accession_number":"0000950170-25-083070","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare stockholders elect three Class I directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Kevin Coop, Jason Krantz, and Lauren Young elected Class I directors with 118M, 117M, and 108M votes for, respectively.","Ratification of Deloitte & Touche as FY2025 auditor passed with 129.4M votes for, 3.0M against, 163K abstain.","Advisory vote on executive compensation approved with 108.6M for, 12.9M against, 167.6K abstain, plus 10.9M broker non-votes.","Record date for the June 5, 2025 annual meeting was April 14, 2025, with 107.96M Class A and 39.0M Class B shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161745,"accession_number":"0000950170-25-066957","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $59.2M (-7% YoY); net loss $155M on $176.5M goodwill impairment; FY guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $59.2M, down 7% YoY; net loss $155.1M including $176.5M goodwill impairment.","Adjusted EBITDA $14.7M (25% margin) vs $20.0M (32% margin) a year ago.","Full-year revenue guidance raised: $234-$240M (prior $230-$240M); reaffirmed adjusted EBITDA margin 26-28%.","Cash flow from operations $26.1M; unlevered free cash flow $22.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":59191000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179835,"accession_number":"0000950170-25-029049","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue $62.3M (-6% YoY); guides FY2025 $230-240M; names Casey Heller CFO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $62.3M, -6% YoY; net loss $(84.7)M including $97.1M goodwill impairment.","Full-year 2024 revenue $252.2M (flat YoY); net loss $(591.4)M with $688.9M impairment.","Q4 adjusted net income $12.6M vs $10.6M; FY adjusted EBITDA $79.1M, 31% margin.","FY2025 revenue guidance $230-240M (down ~5-9% YoY); Q1 rev $55.5-57.0M.","Casey Heller appointed CFO effective June 2, 2025; succeeds Richard Booth (departs June 1)."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":252202000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179834,"accession_number":"0000950170-25-006199","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Definitive Healthcare enters $175M term loan and $50M revolver, maturing Jan 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $175M term loan facility and $50M revolving credit facility with Bank of America as agent; matures January 16, 2030.","Proceeds used to repay outstanding indebtedness under existing credit agreement and pay related fees and expenses.","Term loan amortizes at 5.0% of original principal quarterly starting first full fiscal quarter after closing; balance due at maturity.","Interest rates: ABR plus 1.00%-1.50% or Term SOFR plus 2.00%-2.50%, with two 0.25% step-ups based on total net leverage ratio.","Facilities guaranteed by all wholly-owned domestic restricted subsidiaries and direct parent AIDH Buyer, LLC; secured by substantially all assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196604,"accession_number":"0000950170-24-123356","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","5.02","8.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue beats at $62.7M; CFO Booth to depart June 2025; $100M buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $62.7M, down 4% YoY; net loss $(187.8)M includes $228.2M goodwill impairment; adjusted EBITDA $20.6M (33% margin).","CFO Richard Booth to leave effective June 1, 2025; granted 92,379 RSUs as retention incentive; search for successor underway.","Board authorized $100M stock repurchase program expiring Dec 31, 2025; replaces prior $20M program; no repurchases yet.","Entered voting agreement with Advent International to limit excess voting shares above 40.3% proportionally.","Guidance: Q4 revenue $60-61M, adjusted EBITDA $16-17M; full-year revenue $250-251M, adjusted EBITDA $77.5-78.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":189914000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196603,"accession_number":"0000950170-24-110816","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare promotes Kate Shamsuddin Jensen to COO effective Oct 1","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ms. Shamsuddin Jensen, previously Chief Strategy Officer, named Chief Operating Officer.","New annual base salary of $360,000; eligible for annual cash bonus target of 60% of salary.","Granted 113,379 time-vesting RSUs valued at $500,000 vesting over two years.","Promotion effective October 1, 2024; she joined the company in 2015."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212910,"accession_number":"0000950170-24-090774","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $63.7M (+5% YoY); net loss $(306.2)M on $363.6M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $63.7M (+5% YoY); net loss $(306.2)M including $363.6M goodwill impairment (up 2,538% from $(11.6)M).","Adjusted EBITDA $20.9M (33% margin) vs $17.2M; Adjusted Net Income $14.2M vs $12.4M.","Enterprise customers grew 6% YoY to 537; cash from ops $14.0M, unlevered FCF $21.5M.","Q3 2024 guidance: revenue $61-62.5M; adj. EBITDA $17.5-19M. FY2024 revenue $247-251M; adj. EBITDA $74-77M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":127217000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212909,"accession_number":"0000950170-24-087900","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-07-30T23:59:59+00:00","items":["2.02","5.02"],"status":"ready","headline":"Definitive Healthcare Q2 prelim revenue $63.7M (+5% YoY), goodwill impairment $363.6M; CRO resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Revenue $63.7M (+5% YoY); adjusted EBITDA $20.9M (33% margin) vs $17.2M (28%) YoY.","Net loss $(306.2)M ($(1.81)/share) includes $363.6M goodwill impairment; adjusted net income $0.09/share.","FY2024 guidance: revenue $247-251M, adjusted EBITDA $74-77M (30-31% margin), adjusted EPS $0.32-0.34.","CRO Carrie Lazorchak resigns effective Aug 2, 2024; sales organization reports to CEO Kevin Coop.","Adjusted operating income $19.3M vs $16.0M YoY, up 20.5%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212908,"accession_number":"0000950170-24-082121","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare grants CEO Kevin Coop 186,192 RSUs as make-whole award","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["RSU award granted July 4, 2024 to compensate for equity grant shortfall due to share price volatility.","RSUs vest 25% on July 1, 2025, then 6.25% quarterly over three years, subject to continued employment.","Grant follows CEO appointment effective June 24, 2024, previously disclosed on May 24, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231986,"accession_number":"0000950170-24-064571","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Appoints Kevin Coop as CEO effective June 24; Founder Krantz remains Executive Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Coop appointed CEO effective June 24, 2024; founder Jason Krantz steps down as interim CEO but stays as Executive Chairman.","Coop receives base salary $500k, target bonus 100%, initial RSU grant of $7.5M value, and performance PSUs with stock price hurdles $10-$27.","At annual meeting, stockholders elected three Class III directors, ratified Deloitte as auditor, and approved say-on-pay on a non-binding basis.","2023 Inducement Plan amended to increase reserved shares to 4.4 million for the inducement grants to Coop."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231985,"accession_number":"0000950170-24-054479","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.","Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).","Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.","Board authorized $20M stock repurchase program through end of 2024.","FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":63480000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250265,"accession_number":"0000950170-24-022110","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare reports Q4 rev $65.9M (+9% YoY); FY23 net loss $289.6M; guides FY24 rev $263-269M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $65.9M (+9% YoY); FY23 revenue $251.4M (+13% YoY).","Q4 net loss $13.4M (20% of rev) vs net income $5.9M in Q4 2022; FY23 net loss $289.6M.","Adjusted EBITDA Q4 $19.8M (30% margin); FY23 $74.5M (30% margin).","Guidance: Q1 2024 rev $63–65M (6–10% YoY); FY2024 rev $263–269M (5–7% YoY).","Added 28 enterprise clients in Q4; total enterprise customers at 565 with >$100K ARR."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":251415000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250264,"accession_number":"0001193125-24-008562","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-01-16T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"DH CEO Musslewhite steps down; Founder Krantz interim CEO; reaffirms Q4 guidance, issues 2024 preview","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Robert Musslewhite resigned effective Jan 16, 2024; departure is without cause; receives 15 months accelerated vesting and up to $15K in legal fees.","Founder and Executive Chairman Jason Krantz appointed interim CEO, effective Jan 16, 2024; Board engaged search firm for permanent CEO.","Company reaffirms Q4 2023 guidance provided on Nov 3, 2023; preliminary 2024 guidance: revenue growth 5-7% YoY, Adj. EBITDA margin +~200 bps.","Krantz previously served as CEO from 2011 to Aug 2022, scaling the company to >$200M revenue and IPO in Sept 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":250263,"accession_number":"0000950170-24-001529","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2024-01-04T23:59:59+00:00","items":["2.05","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare cuts 154 jobs, expects $6.5M-$7.2M restructuring charges","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Workforce reduced by 154 employees as part of restructuring plan announced Jan 3, 2024.","Estimated pre-tax cash charges of $6.5M to $7.2M in H1 2024; plus $1.5M non-cash share-based charge.","Restructuring aims to reduce costs and improve margins; substantially complete by Q2 2024.","CEO cites 'Go for GOLD' transformation; severance includes 3-month salary, equity acceleration, 6-month benefits.","Company plans to reinvest savings into key growth areas and add new roles over the next year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267812,"accession_number":"0000950170-23-065480","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-11-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Definitive Healthcare adopts executive severance plan with up to 9 months of benefits","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Eligible employees get 9 months salary continuation (tenured ≥2 yrs) or 6 months (<2 yrs).","Prorated annual target bonus payable only if Qualifying Termination occurs on/after July 1.","Time-based equity awards accelerate vesting through 9 or 6 months post-separation.","COBRA premium reimbursement for up to 6 or 9 months; benefits contingent on signing a release.","Plan effective Nov. 17, 2023; non-duplicative with other severance arrangements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267811,"accession_number":"0000950170-23-058213","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue $65.3M (+14% YoY); net loss widens to $248.7M on non-cash charges","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $65.3M, up 14% YoY from $57.4M; above high-end of guidance.","Net loss $248.7M (381% of revenue) vs $6.9M loss in Q3 2022; adjusted net income $14.6M.","Adjusted EBITDA $21.7M (33% of revenue) vs $16.4M (29%) a year ago.","Q4 guidance: revenue $65.5M-$66.5M, adjusted EPS $0.06-$0.08 on 155.6M diluted shares.","Enterprise customers grew 10% YoY to 555; customer win-backs and expansions noted."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":185483000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":267810,"accession_number":"0000950170-23-052203","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-10-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare names Carrie Lazorchak as CRO; Mirisola to depart Dec 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CRO Joe Mirisola resigns effective Nov 1, 2023; remains Senior Advisor through Dec 31, 2023.","Separation agreement provides 9 months base salary, 2023 bonus, COBRA, and equity acceleration.","Carrie Lazorchak appointed CRO effective Nov 1, 2023; formerly CRO at SimilarWeb.","Mirisola, first employee hired in 2011, helped grow revenue from $0 to $240M.","Lazorchak will lead sales organization to expand client base and drive operational excellence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285037,"accession_number":"0000950170-23-047275","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-09-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare appoints former Verisk CEO Scott Stephenson to board; Chris Mitchell resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chris Mitchell (Spectrum Equity) resigned from board effective Sept 6, 2023; not due to any disagreement.","Scott Stephenson, former CEO of Verisk Analytics (VRSK), appointed to board and nominating & corporate governance committee.","Stephenson served as Verisk CEO for nine years and also serves on board of Public Service Enterprise Group (PEG).","Stephenson will serve as Class III director until the 2024 Annual Meeting of Stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285036,"accession_number":"0000950170-23-042417","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $61M (+12% YoY), acquires Populi; guides Q3 rev $63-64.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $61.0M (+12% YoY); net loss widened to $11.6M from $10.1M; adjusted EBITDA $17.2M (28% of revenue).","Acquired Populi, a provider-focused data and analytics company; strengthens Atlas Dataset with new data and analytic tools for provider market.","Restated prior financials due to sales tax misstatements; aggregate G&A increase of $8.5M through March 2023.","Q3 2023 guidance: revenue $63-64.5M, adjusted EBITDA $17.5-18.5M, adjusted EPS $0.05-0.07.","Full-year 2023 guidance: revenue $249-255M, adjusted EBITDA $67-71M, adjusted EPS $0.19-0.23; expects revenue in lower half, profitability in upper half."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":120158000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285035,"accession_number":"0000950170-23-036178","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["2.02","2.05","4.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare restates prior financials due to sales tax error; Q2 rev $61M, cuts 4% workforce","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restates 2020-2022 and Q1 2023 financials over sales tax; expects G&A expense increase of $6.8M-$10.2M.","Preliminary Q2 revenue $61M, net loss $11.4-11.8M, adj. EBITDA $17.2M; reaffirms FY revenue $249-255M and adj. EBITDA $67-71M.","Cuts 42 jobs (~4% workforce); expects pre-tax restructuring charges of $1.8M-$2.0M in Q3 2023.","Material weakness in internal control over financial reporting identified; Q2 2023 earnings call moved to Aug 14."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304857,"accession_number":"0000950170-23-027023","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-06-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Definitive Healthcare CRO Joseph Mirisola resigns; transition through Dec 31, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph Mirisola notified board of intent to resign as Chief Revenue Officer on June 8, 2023.","Resignation effective on or around Dec 31, 2023, pending successor identification and transition.","Mirisola was one of the first employees and has served for 12 years; will assist in transition.","No replacement named yet; CEO Robert Musslewhite signed the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304856,"accession_number":"0000950170-23-026360","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-06-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare stockholders elect four Class II directors; set advisor vote on exec pay at one year","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Chris Egan, Samuel Hamood, Jill Larsen, Sastry Chilukuri elected as Class II directors with >130M votes each.","Advisory vote on frequency of executive compensation: 144.4M (1 year) vs. 305,719 (2 years) vs. 218,960 (3 years).","Ratification of Deloitte & Touche as independent auditor for FY2023: 144.5M for, 2.5M against.","Annual meeting held June 1, 2023; record date April 3, 2023 with 110.2M Class A and 44.2M Class B shares outstanding.","Board determined future advisory votes on executive compensation will occur every year until next required frequency vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":304855,"accession_number":"0000950170-23-017910","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $59.2M (+18% YoY); net loss $15.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $59.2M (+18% YoY from $50.1M); net loss $15.6M vs $13.1M prior year.","Adjusted net income $9.2M, up from $7.7M; adjusted EBITDA $15.7M (26% of revenue).","Q2 2023 guidance: revenue $60.5-$61.5M; full-year 2023 rev $249-255M (+12-15% YoY).","Launched DefinitiveConnect for Salesforce integration and Atlas AI analytics suite.","Enterprise customers: 529 with >$100K ARR; won deals with pharma, hospital, and non-profit clients."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":59201000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":324375,"accession_number":"0000950170-23-004128","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-02-23T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue up 31% to $60.6M; FY23 guidance implies 14% growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $60.6M (+31% YoY); GAAP net income $6.7M vs loss $14.8M in Q4 2021.","Full year 2022 revenue $222.7M (+34%); GAAP net loss $22.3M vs $61.3M loss prior year.","Adjusted EBITDA Q4 $17.0M (28% margin); full year $63.7M (29% margin).","Q1 2023 revenue guidance $56.5-58.5M (median +15% YoY); FY2023 revenue $249-255M (+14% at midpoint).","Executive Chairman Jason Krantz base salary reduced to $1,000/week, granted 18,465 RSUs, no 2023 bonus; CEO/CFO/Chairman received cash bonuses for 2022 despite missing targets."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":222653000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":324374,"accession_number":"0001193125-23-006944","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2023-01-12T23:59:59+00:00","items":["2.05","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare cuts ~6% of staff (55 employees) under restructuring plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reduction of approx. 55 employees (~6% of workforce) announced Jan 12, 2023.","Pre-tax cash charges of $2.0M-$2.5M expected in Q1 2023, mainly severance and benefits.","Restructuring substantially complete by end of Q1 2023; non-cash stock-based comp charge immaterial.","CEO cites economic slowdown and need to reduce cost structure after rapid hiring growth.","Affected employees get salary continuation (min 3 months), benefits (min 6 months), accelerated equity vesting through Mar 31."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":342277,"accession_number":"0000950170-22-021909","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-11-03T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue $57.4M (+33% YoY); net loss narrows; appoints Jon Maack as President","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $57.4M (+33% YoY), net loss $6.4M vs $21.0M; adjusted EBITDA $16.4M (29% revenue).","Q4 revenue guidance $58-59M (median +26% YoY); full-year 2022 revenue guidance $220-221M.","Jon Maack appointed President, effective Nov 3, 2022; reports to CEO; oversees product, engineering, strategy, M&A.","Maack received $400k base salary, 70% bonus target, 546k RSUs; previously Chief Strategy Officer at athenahealth.","Unlevered free cash flow $15.5M (27% revenue) in Q3; trailing twelve-month $67.4M (32% revenue)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":162054000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":342276,"accession_number":"0001193125-22-256657","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-10-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare appoints Sastry Chilukuri to board; Randy Winn departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sastry Chilukuri, co-CEO of Medidata, joins board and audit committee effective Sept 30, 2022.","Randy Winn (22C Capital) steps down after serving since 2019; Chilukuri replaces him.","Chilukuri receives pro-rated annual retainer of $50k, initial RSU grant of 19,306 shares, and pro-rated annual RSU of 7,282 shares.","Chilukuri’s appointment aligns with expanding life sciences presence; he has 22+ years in healthcare technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359031,"accession_number":"0001193125-22-212516","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q2 revenue $54.5M (+37% YoY); net loss narrows; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $54.5M (+37% YoY); net loss ($9.6M) improved from ($15.0M) in Q2 2021.","Adjusted Net Income $8.9M (vs $2.0M); Adjusted EBITDA $16.3M (30% of revenue).","Enterprise customers (ARR >$100k) reached 486; launched Passport Express and Monocl ExpertInsight 2.0.","Q3 2022 revenue guidance $56-57M; FY 2022 revenue guidance $220.5-224.5M (34% YoY growth midpoint).","Unlevered free cash flow $19.1M in Q2; trailing twelve months $63.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":104672000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377844,"accession_number":"0001193125-22-160977","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-05-26T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Definitive Healthcare stockholders elect three Class I directors, ratify Deloitte as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Jason Krantz, Chris Mitchell, Lauren Young elected as Class I directors with ~141.8M, ~134.7M, ~132.6M votes for respectively.","Auditor ratification passed with ~146.6M for, only 700 against.","Broker non-votes of 310,487 on all director proposals.","Meeting held May 24, 2022; record date March 25, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":377843,"accession_number":"0001193125-22-142304","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q1 revenue $50.1M (+36% YoY); CEO transition to Musslewhite in August","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Revenue $50.1M, +36% YoY; net loss ($13.1M) widened from ($10.5M); adjusted net income $7.7M (vs $2.6M).","Adjusted EBITDA $14.0M (28% of revenue) vs $14.1M (38%) in Q1 2021; cash from ops $13.6M.","Q2 2022 guidance: revenue $53-54M (+34%); full year revenue $220.5-224.5M (+33-35%).","Robert Musslewhite (President) appointed CEO effective Aug 1, 2022; founder Jason Krantz becomes Executive Chairman.","Musslewhite receives annual base salary $429k, RSU grants, and change-in-control benefits; Krantz retains reduced salary and equity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":396151,"accession_number":"0001193125-22-049951","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2022-02-23T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Definitive Healthcare Q4 revenue up 38% to $46.3M; acquires Analytical Wizards for $65M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $46.3M (+38% YoY); GAAP net loss $14.8M, adjusted net income $6.6M.","Full year 2021 revenue $166.2M (+40%); adjusted EBITDA $56.0M (34% of revenue).","Q1 2022 revenue guidance $47-49M; FY2022 revenue guidance $218-222M.","Acquired Analytical Wizards for $65M cash plus up to $5M contingent on expense metrics.","Ended Q4 with 417 enterprise customers (>= $100k ARR); launched Latitude Reporting."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":166154000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415169,"accession_number":"0001193125-21-330236","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2021-11-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Definitive Healthcare enters stock/unit purchase agreement with selling securityholders","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Agreement dated Nov 10, 2021 to purchase a portion of Class A common stock and/or AIDH TopCo LLC units from certain Sellers.","Private, non-underwritten transaction; no price or number of shares disclosed in the 8-K.","Full agreement incorporated by reference to Exhibit 10.21 of the Registration Statement filed Nov 15, 2021.","Transaction is between the company and its securityholders; no public offering or exchange involved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415168,"accession_number":"0001193125-21-323040","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2021-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Definitive Healthcare Q3 revenue up 43% to $43.1M; GAAP net loss widens to $21M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $43.1M (+43% YoY); adjusted EBITDA $14.4M (33% margin) vs $14.5M (48% margin) a year ago.","GAAP net loss $(21.0)M vs $(10.0)M in Q3 2020; adjusted net income $2.2M down from $5.1M.","Ended Q3 with 377 $100k+ ARR customers, up 49% vs 252 a year earlier.","Q4 FY2021 guidance: revenue $44-45M, adjusted EBITDA $12.5-13.5M, adjusted EPS $0.04-0.05."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":119841000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415167,"accession_number":"0001193125-21-295520","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2021-10-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Definitive Healthcare appoints former OptumInsight CEO Robert Musslewhite as President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Musslewhite appointed President, a newly created role, effective Oct 7, 2021; he had been a board member since June 2021.","Compensation: $429k base salary, bonus up to 68% of base; RSUs of 433,550 shares (4-yr vest) and 216,450 shares (3-yr vest).","Musslewhite previously served as CEO of OptumInsight (2019-2021) and as CEO/Chairman of The Advisory Board Company.","Employment agreement includes change-in-control/termination benefits; Musslewhite remains on the board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":415166,"accession_number":"0001193125-21-289665","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2021-10-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Definitive Healthcare appoints former ADP CFO Kathleen Winters to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kathleen A. Winters elected to board of directors and Audit Committee, effective Oct 1, 2021.","Winters served as ADP CFO from 2019 through Sep 2021; previously CFO of MSCI Inc.","She spent 14 years in financial leadership roles at Honeywell International.","CEO Jason Krantz cites her financial and operational experience as key for public-company growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":433084,"accession_number":"0001193125-21-277423","cik":1861795,"company_name":"Definitive Healthcare Corp.","ticker":"DH","form_type":"8-K","filed_at":"2021-09-20T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Definitive Healthcare closes IPO of 17.9M shares at $27, raising ~$483M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed IPO of 17,888,888 shares (includes overallotment) at $27.00/share, gross proceeds ~$483M.","Entered $275M term loan A and $75M revolver due 2026 with Bank of America, replacing existing debt.","Term loan amortizes quarterly starting Dec 2021: 2.5%/yr first two years, then 5%/yr.","Interest rate options: base rate + 0.75%-1.25% or LIBOR + 1.75%-2.25%, based on leverage.","Facilities secured by substantially all assets of DHH and its guarantors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":125723370.18186054,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}